Cosmos Health Inc. financial data

Symbol
COSM on Nasdaq
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Location
5 Agiou Georgiou, Pilea, Thessaloniki, Greece
State of incorporation
NV
Fiscal year end
December 31
Former names
Cosmos Holdings Inc. (to 12/19/2022), PRIME ESTATES & DEVELOPMENTS INC (to 1/3/2014)
Latest financial report
10-K - Q4 2024 - Apr 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 130 % -37.3%
Quick Ratio 18.6 % -19.9%
Debt-to-equity 91.8 % +46.6%
Return On Equity -51.3 % -16.1%
Return On Assets -26.8 % +1.15%
Operating Margin -28.6 % +30.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.3M shares
Common Stock, Shares, Outstanding 23.6M shares +48.5%
Entity Public Float 16.6M USD -42.5%
Common Stock, Value, Issued 23.7K USD +48.2%
Weighted Average Number of Shares Outstanding, Basic 18.4M shares +46.3%
Weighted Average Number of Shares Outstanding, Diluted 18.4M shares +46.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 54.4M USD +1.97%
Selling and Marketing Expense 355K USD -70.5%
General and Administrative Expense 11.7M USD -40.3%
Operating Income (Loss) -15.5M USD +28.8%
Nonoperating Income (Expense) -638K USD -119%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.2M USD +12.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -16.2M USD +12.7%
Earnings Per Share, Basic -1.17 USD/shares +45.6%
Earnings Per Share, Diluted -1.17 USD/shares +45.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.23M USD +297%
Marketable Securities, Current 21.1K USD +5.35%
Accounts Receivable, after Allowance for Credit Loss, Current 13.5M USD -31.8%
Inventory, Net 4.36M USD -9.06%
Assets, Current 25.5M USD -30.4%
Property, Plant and Equipment, Net 9.69M USD -6.22%
Operating Lease, Right-of-Use Asset 696K USD -38.5%
Intangible Assets, Net (Excluding Goodwill) 7.71M USD -0.66%
Goodwill 49.7K USD 0%
Assets 54.3M USD -17.7%
Accrued Liabilities, Current 222K USD +33.3%
Liabilities, Current 25.8M USD +5.9%
Operating Lease, Liability, Noncurrent 498K USD -41%
Other Liabilities, Noncurrent 1.96M USD +11.1%
Liabilities 29.8M USD -0.64%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.13M USD -409%
Retained Earnings (Accumulated Deficit) -114M USD -24.4%
Stockholders' Equity Attributable to Parent 24.5M USD -31.9%
Liabilities and Equity 54.3M USD -17.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.41M USD +46.2%
Net Cash Provided by (Used in) Financing Activities 207K USD -90.8%
Net Cash Provided by (Used in) Investing Activities 126K USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 23.7M shares +48.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.97M USD +65.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 315K USD -91.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 235K USD -60.1%
Depreciation 387K USD +9.63%
Payments to Acquire Property, Plant, and Equipment 82.7K USD +218%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -24.1M USD +3.9%
Property, Plant and Equipment, Gross 11M USD -2.88%
Operating Lease, Liability, Current 197K USD -31.1%
Deferred Tax Assets, Operating Loss Carryforwards 38.5M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Operating Lease, Payments 41.1K USD +67.8%
Additional Paid in Capital 142M USD +9.75%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 794K USD +231%
Depreciation, Depletion and Amortization 312K USD +335%
Share-based Payment Arrangement, Expense 2.38K USD
Interest Expense 1.01M USD +16.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%